Skip to content

Author

Jun-Kang Ren

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Bridging DNA damage and cGAS-STING activation: Platinum (IV) prodrugs as single-molecule chemo-immunotherapeutics.

Cisplatin-based chemotherapy remains a cornerstone in cancer treatment, yet its clinical utility is often hampered by severe systemic toxicity and the cold immune microenvironment of many tumors. To address these challenges, we leveraged the kinetically inert nature and structural versatility of the Platinum (IV) [Pt (...

Jun-Kang Ren, Jia-Ni Wu, Xin-Yu Dai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.